Your browser doesn't support javascript.
loading
Association of PD-L1 expression status with the efficacy of PD-1/PD-L1 inhibitors and overall survival in solid tumours: A systematic review and meta-analysis.
Liu, Xi; Guo, Chang-Ying; Tou, Fang-Fang; Wen, Xiao-Ming; Kuang, Yu-Kang; Zhu, Qian; Hu, Hao.
Afiliação
  • Liu X; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, China.
  • Guo CY; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, China.
  • Tou FF; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, China.
  • Wen XM; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, China.
  • Kuang YK; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, China.
  • Zhu Q; Department of Intensive Care Unit, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hu H; Department of Thoracic Surgery, Jiangxi Cancer Hospital, Nanchang, China.
Int J Cancer ; 147(1): 116-127, 2020 07 01.
Article em En | MEDLINE | ID: mdl-31633798
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Imunológicos / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China